Success Metrics

Clinical Success Rate

33.3%

Based on 1 completed trials

Completion Rate

33%(1/3)

Active Trials

0(0%)

Results Posted

200%(2 trials)

Terminated

2(67%)

Phase Distribution

Ph phase_4

33%

Ph not_applicable

67%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 4Post-market surveillance

1(33.3%)

N/ANon-phased studies

2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(1)

Terminated(2)

Detailed Status

Terminated2

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

33.3%

Most Advanced

Phase 4

Trials by Phase

Phase 41 (33.3%)

N/A2 (66.7%)

Trials by Status

terminated267%

completed133%

Recent Activity

0 active trials

Showing 3 of 3

completednot_applicable

Polytetrafluoroethylen (PTFE) Vascular Prostheses With Heparin Bonded Luminal Surfaces vs Crude ePTFE

NCT03430076

terminatedphase_4

Artegraft Versus Propaten Dialysis Grafts

NCT02099344

terminatednot_applicable

Propaten Randomized Investigation on Cost-benefit and Efficacy

NCT01601873

Clinical Trials (3)

Showing 3 of 3 trials

NCT03430076Not Applicable

Polytetrafluoroethylen (PTFE) Vascular Prostheses With Heparin Bonded Luminal Surfaces vs Crude ePTFE

Completed

NCT02099344Phase 4

Artegraft Versus Propaten Dialysis Grafts

Terminated

NCT01601873Not Applicable

Propaten Randomized Investigation on Cost-benefit and Efficacy

Terminated

All 3 trials loaded

Drug Details

Intervention Type: DEVICE
Total Trials: 3